Kevin Lee, CHIEF EXECUTIVE OFFICER at BICYCLE THERAPEUTICS PLC (BCYC), sold 7,683 shares at $4.91 ($38K) on 2026-04-02, disclosed to the SEC on 2026-04-06.
Seasonal sale ($38k) by CHIEF EXECUTIVE OFFICER — this insider has traded BCYC in April in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.91 | 5,967 | $29K | 77.2% |
| 2 | $5.05 | 1,716 | $9K | 22.8% |
| Total | $4.94 avg | 7,683 | $38K | 100% |
| Filing → |
| BCYC | SELL | 2026-01-06 | $141K | — | Filing → |
| BCYC | SELL | 2025-10-06 | $46K | — | Filing → |
| BCYC | SELL | 2025-07-07 | $40K | — | Filing → |